Cancer data pooling study aims to connect the dots across trials

NCT ID NCT03269578

Recruiting now Knowledge-focused Sponsor: National Cancer Institute (NCI) Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study enrolls adults with cancer or benign tumors who are already participating in other trials at the National Cancer Institute. Researchers will collect and link medical records and research samples from all of a patient's past, current, and future studies. The goal is to track how cancers respond to different treatments over time, without requiring any new tests or procedures from participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help researchers better understand how different cancers respond to treatments over time, potentially guiding future therapies.
What could go wrong: This is an observational data-collection study, not a treatment trial. It does not test any new drug or intervention, so direct patient benefits are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign neoplasm cancer lymphoma neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHOMA NEOPLASMS

Contacts and locations

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.